Skip to main content

Carlos Jacas Escarcellé

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Carlos Jacas Escarcellé

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Repercusión de la "dilatación" beniga de los espacios subaracnoideos en el desarrollo psicomotor y cognitivo de los niños

IP: Ma Antonia Poca Pastor
Collaborators: Gustau Perez Prat , Carlos Jacas Escarcellé, Noelia Montoya Clemente, Jannet Paola Cano Granda
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI18/00468
Duration: 01/01/2019 - 31/12/2022

Psiquiatria, Salut Mental i Addiccions

IP: Miquel Casas Brugué
Collaborators: Natalia Calvo Piñero, Carlos Jacas Escarcellé, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez, Maria Soler Artigas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35200
Reference: 2017SGR1461
Duration: 01/01/2017 - 30/09/2021

Desarrollo de métodos predictivos basados en la integración de factores prenatales y postnatales para la detección de neurodesarrollo anómalo en cardiopatías congénitas

IP: Maria Queralt Ferrer Menduiña
Collaborators: Itziar Garcia Ruiz, Josefa Élida Vázquez Méndez, Francisca Munar Bauza, Carlos Jacas Escarcellé, Joan Sanchez de Toledo Sancho, Silvia Arévalo Martínez, Elisa Llurba Olivé
Funding agency: Instituto de Salud Carlos III
Funding: 106722
Reference: PI13/01449
Duration: 01/01/2014 - 30/06/2018

Estudio multidimensional del espectro de los trastornos relacionados con la exposición prenatal al alcohol

IP: -
Collaborators: Núria Gómez Barros, Carlos Jacas Escarcellé, Susana Boronat Guerero, Anna Maria Cueto Gonzalez
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI12/02289
Duration: 01/01/2013 - 31/12/2015

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Josefa Mª Heredia Montiel

Josefa Mª Heredia Montiel

Administration and Management
Physiology and Pathophysiology of the Digestive Tract
Read more
Luis Carrera Calderer

Luis Carrera Calderer

Reconstructive Surgery of the Locomotor System
Read more
Nuria Nogués Gálvez

Nuria Nogués Gálvez

Transfusional Medicine
Read more
Anna González Tallada

Anna González Tallada

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.